Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

Inclusion Criteria: * The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 1 month of follow-up * The patient understands and reads French * The patient has symptoms of overactive bladder resistant to first-line treatments (physiotherapy, anticholinergics) * The patient suffers from an overactive bladder confirmed by a urodynamic panel * The patient suffers from an overactive bladder unassociated with bladder obstruction as confirmed by flowmetry * The patient has primary (idiopathic) overactive bladder primary with normal urinalysis, abdominal and pelvic ultrasound, urine cytology + / - cystoscopy * The patient has no bleeding disorders, or the disorder is properly controlled after treatment Exclusion Criteria: * The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant, parturient, or breastfeeding * Overactive bladder associated with bladder obstruction as determined by flowmetry * Overactive bladder unconfirmed by urodynamic panel * Overactive bladder secondary to another condition: * vesical: urolithiasis, bladder polyp, interstitial cystitis * pelivienne: tumor or inflammatory * neurological: multiple sclerosis, brain tumor, epilepsy * the patient has an uncorrectable bleeding disorder